Felicitex Therapeutics Inc. (FLCT)

Felicitex Therapeutics will go public soon, but the exact IPO date is still unknown.

IPO Price

$6.25

Shares Offered

2,480,000

Deal Size

$15.50M

Felicitex Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	45	-	-
Enterprise Value	45	-	-
Debt / Equity Ratio	-0.29	-0.32	-0.70
Debt / EBITDA Ratio	-0.14	-0.19	-0.97
Debt / FCF Ratio	-0.22	-0.29	-0.54
Quick Ratio	0.03	0.01	0.05
Interest Coverage	-185.74	-	-17.36
Return on Equity (ROE)	202.60%	169.85%	94.71%
Return on Assets (ROA)	-	-8541.99%	-1534.91%
Return on Capital (ROIC)	290.45%	260.62%	491.27%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).